(NEXSTAR) – Pfizer received full FDA approval for its vaccine and all of a sudden there’s a new vaccine name being thrown around: Comirnaty. Comirnaty, who? It’s the same exact mRNA vaccine Pfizer has produced through the emergency use authorization, but now it’s being marketed under the new name. Comirnaty is administered in two doses, three weeks apart, just like Pfizer doses have been all along.
Story continues below
- Entertainment: Concerts coming to New Mexico in 2022
- New Mexico: Tribal community receives millions for wastewater infrastructure
- Crime: Prosecutors say son of man charged in Muslim murders connected to shootings
- Rankings: Cities with the fastest-growing home prices in New Mexico
- Always On: Props from Better Call Saul to be auctioned off
The vaccine name is pronounced koe-mir’-na-tee. It doesn’t exactly roll off the tongue, but neither did “Pfizer-BioNTech COVID-19 Vaccine,” which is what it was technically called before.
The name was developed by Brand Institute in conjunction with BioNTech and Pfizer, according to Fierce Pharma.
“The name is coined from COVID-19 immunity, and then embeds the mRNA in the middle, which is the platform technology, and as a whole the name is meant to evoke the word community,” Scott Piergrossi, Brand Institute president of operations and communications, told the site.
The rebranding didn’t go unnoticed – nor unpunished – on social media.
Pfizer’s vaccine isn’t the only one with an alter ego. Moderna’s is branded as Spikevax in Europe. The one-shot Johnson & Johnson shot is technically called the Janssen COVID-19 vaccine after the American company’s Belgian subsidiary Janssen Pharmaceuticals.